In one paragraphArticle in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Roko GranićDepartment of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, 10 000 Zagreb, Croatia.
Ivan BlažekovićDepartment of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, 10 000 Zagreb, Croatia.ORCID 0009-0003-7665-0069 Josipa MišDepartment of Clinical Chemistry, University Hospital Center Sestre Milosrdnice, 10 000 Zagreb, Croatia.ORCID 0000-0002-1734-0015 Ivan ŠamijaDepartment of Clinical Chemistry, University Hospital Center Sestre Milosrdnice, 10 000 Zagreb, Croatia.ORCID 0000-0002-5633-5745 Tihana Regović DžombetaDepartment of Pathology Ljudevit Jurak, University Hospital Center Sestre Milosrdnice, 10 000 Zagreb, Croatia.ORCID 0000-0002-8858-3524 Gorana MiroševićSchool of Dental Medicine, University of Zagreb, 10 000 Zagreb, Croatia.
Denis BakunićSchool of Medicine, University of Zagreb, 10 000 Zagreb, Croatia.
Kristina KralikFaculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, 31 000 Osijek, Croatia.ORCID 0000-0002-4481-6365 Ana FröbeDepartment of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, 10 000 Zagreb, Croatia.
Zvonko KusićCroatian Academy of Sciences and Arts, 10 000 Zagreb, Croatia.
Tomislav JukićDepartment of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, 10 000 Zagreb, Croatia.ORCID 0000-0001-5631-164X Funding
Croatian Science Foundation IP-2019-04-1130
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Iodine RadioisotopesProto-Oncogene Proteins B-rafTelomeraseThyroid NeoplasmsAdultAgedFemaleHumansMaleMiddle AgedMutationPrognosisPromoter Regions, GeneticTreatment OutcomeBRAF protein, humanIodine-131Iodine RadioisotopesProto-Oncogene Proteins B-rafTelomeraseTERT protein, humanBRAFV600Edifferentiated thyroid canceriodine-131mutationprognosisTERT promotertreatment response
Identifiers
PMID42353802
PMCPMC13299577
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390